Moderna Says Its COVID-19 Vaccine Was Well-Tolerated And Generated Robust Immune Response In Childre

1 Philadelphia

Philadelphia News & Search

1 News - 1 eMovies - 1 eMusic - 1 eBooks - 1 Search

Interim results of a Phase 2/3 trial showed Moderna’s Covid-19 vaccine was well-tolerated and generated a robust immune response in children ages 6 to 11, the company said Monday. Katie Johnston reports.


1 Philadelphia

Philadelphia News & Search

1 News - 1 eMovies - 1 eMusic - 1 eBooks - 1 Search


Facebooktwitterredditpinterestlinkedinmail

Facebooktwitterlinkedinrssyoutube

Leave a Reply